Assertio Holdings (ASRT) Total Current Liabilities (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Total Current Liabilities came in at $91.6 million in Q1 2026, down 28.92% year-on-year from $128.8 million in Q1 2025, and down 28.19% quarter-over-quarter from $127.5 million in Q4 2025.

Assertio Holdings (ASRT) Total Current Liabilities (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Total Current Liabilities across 8 years of filings, most recently posting $91.6 million for Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $91.6 million, down 28.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.6 million (down 28.92% YoY), and the FY2025 annual result was $127.5 million, up 11.18% from the prior year.
  • Total Current Liabilities came in at $91.6 million for Q1 2026 at Assertio Holdings, down from $127.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $166.8 million in Q3 2025 to a low of $79.5 million in Q2 2023.
  • The 5-year median for Total Current Liabilities is $95.3 million (2022), against an average of $109.5 million.
  • Across the five-year window, Total Current Liabilities slumped 31.75% in 2023 and jumped 85.1% in 2025, its largest moves.
  • Assertio Holdings' Total Current Liabilities stood at $95.3 million in 2022, then decreased by 1.97% to $93.4 million in 2023, then rose by 22.74% to $114.7 million in 2024, then grew by 11.18% to $127.5 million in 2025, then dropped by 28.19% to $91.6 million in 2026.
  • The last three Total Current Liabilities figures came in at $91.6 million (Q1 2026), $127.5 million (Q4 2025), and $166.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.53 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.05 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 831.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 1.66 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 599.50 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 618.78 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 333.17 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 91.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 91.57 Mn
Dec 31, 2025 127.51 Mn
Sep 30, 2025 166.78 Mn
Jun 30, 2025 132.53 Mn
Mar 31, 2025 128.83 Mn
Dec 31, 2024 114.69 Mn
Sep 30, 2024 90.10 Mn
Jun 30, 2024 92.18 Mn
Mar 31, 2024 92.44 Mn
Dec 31, 2023 93.44 Mn
Sep 30, 2023 114.29 Mn
Jun 30, 2023 79.48 Mn
Mar 31, 2023 94.55 Mn
Dec 31, 2022 95.32 Mn
Sep 30, 2022 92.30 Mn
Jun 30, 2022 116.15 Mn
Mar 31, 2022 138.53 Mn
Dec 31, 2021 135.02 Mn
Sep 30, 2021 100.48 Mn
Jun 30, 2021 116.91 Mn